Greg Maurer discuss the uncertainty at the FDA on Inside Indiana Business
June 6, 2013
The U.S. Food and Drug Administration's mission includes both the advancement of public health by helping to speed innovation and the assurance of the safety and efficacy of new and innovative products. However, the current balance struck at the FDA has curtailed innovation and, if not rectified, will negatively affect the availability of innovative medical products in the future.
Hear what Heron Capital's Managing Director, Greg Maurer, has to say about uncertainty at the FDA.
AirXpanders Announces First Commercial U.S. Procedure for AeroForm® Tissue Expander System for Breast Reconstruction
January 18, 2017
US FDA grants de novo clearance to AirXpanders' AeroForm Tissue Expander System for breast reconstruction
December 26, 2016
First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation
November 9, 2016